AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Bioreactors Market Will Grow at a CAGR of 7% During 2019-2023 | Technavio

March 19, 2019
The global bioreactors market is expected to post a CAGR of almost 7% during the period 2019-2023. (Graphic: Business Wire)

LONDON--(BUSINESS WIRE)--Mar 19, 2019--Technavio has announced the release of their research report on the global bioreactors market for the forecast period 2019-2023. This bioreactors market analysis report segments the market by end-users (biopharmaceutical companies, research institutes, and contract research organizations) and geography (Asia, Europe, North America, and ROW).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190319005511/en/

The global bioreactors market is expected to post a CAGR of almost 7% during the period 2019-2023. (Graphic: Business Wire)

There is a growing demand for single-use bioreactors as these bioreactors are easy to use when compared to stainless steel bioreactors. The primary reason being single-use bioreactors can be set up much more smoothly for continuous processing. A single-use bioreactor used in a fed-batch manufacturing process can be converted to fit the requirements of a continuous processing operation. Customization can only be conducted on the process-specific consumable parts; the vessel stays the same irrespective of the process mode. In the case of stainless-steel bioreactor, a similar change would lead to an extensive revamp of the entire infrastructure of the facility which would result in additional investments.

The advent of start-ups and continuous technological advances by current players

The steady growth of the bioreactors market has enabled emerging start-ups to make use of bioreactor technology for the development of advanced medical procedures. For instance, companies are seen developing bioreactors that are capable of performing a chemical bath for a piece of human tissue for three weeks. High metabolism and weight loss are being observed when the tissue is reinserted into the body after the chemical bath process. After processing, the tissues are sent back to the end-user company’s office to be worked in a bioreactor. Similarly, other players are also in the process of developing bioreactors at a low-cost and provide an open solution for end-users. The demand for bioreactors is expected to increase, as such procedures help in treating people suffering from obesity.

Request for a FREE sample and get selected illustrations, table of contents, list of exhibits, and example pages from this report.

“Pharmaceutical companies in Europe are constantly making efforts to plan and adopt the quality by design approach in their manufacturing processes as the European region is expected to register the highest incremental growth during the forecast period. Moreover, several organizations are seen providing information for testing and aid in analyzing the laboratory community and further assisting in infrastructural support to facilitate efficient scientific and technical cooperation among European member countries. Such factors are augmenting the use of bioreactors,” says an analyst at Technavio.

To increase their bioreactors market share, manufacturers are focusing on collaborating with other players in the market. GE Healthcare has collaborated with Jacobs Engineering Group to develop the Pfizer’s USD 350 million monoclonal antibody manufacturing center in China. Jacobs Engineering Group has also been involved with other biomanufacturing facilities such as Merck KGaA, Novartis, and Bristol-Myers Squibb.

View snapshot of the report for a more detailed overview of the market and the segmentation covered in this report

This bioreactors industry research report provides an in-depth analysis of the primary drivers, upcoming trends, and challenges that will impact market growth over the forecast period. The report analyzes the competitive landscape and offers details on several bioreactors manufacturers including –

  • Danaher
  • GE Healthcare
  • Merck KGaA
  • Sartorius
  • Thermo Fisher Scientific

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. Technavio’s report library consists of more than 10,000 reports covering 800 technologies, spanning across 50 countries. Their client base includes enterprises of all sizes, including more than 100 Fortune 500 companies.

Please contact our media team at media@technavio.com for more information

View source version on businesswire.com:https://www.businesswire.com/news/home/20190319005511/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: TECHNOLOGY OTHER TECHNOLOGY HEALTH BIOTECHNOLOGY PHARMACEUTICAL MANUFACTURING CHEMICALS/PLASTICS ENGINEERING PROFESSIONAL SERVICES CONSULTING RESEARCH SCIENCE GENERAL HEALTH

SOURCE: Technavio Research

Copyright Business Wire 2019.

PUB: 03/19/2019 09:00 AM/DISC: 03/19/2019 09:01 AM

http://www.businesswire.com/news/home/20190319005511/en